Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis. 2017

Lihi Atzmony, and Ilit Mimouni, and Ofer Reiter, and Yael Anne Leshem, and Omar Taha, and Michael Gdalevich, and Emmilia Hodak, and Daniel Mimouni
Department of Dermatology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: lihiatzmony@gmail.com.

BACKGROUND Studies evaluating whether malignancy rate is increased in patients with bullous pemphigoid (BP) have reached conflicting results. OBJECTIVE We sought to determine whether BP is associated with malignancy. METHODS Medline, EMBASE, the Cochrane library, and reference lists of included studies were searched for comparative studies that evaluated the relationship between BP and malignancy. Data were analyzed on the basis of study design: cross-sectional, case control, and cohort. A meta-analysis was performed by using a random effects model to estimate pooled odds ratio. RESULTS The review included 8 studies. No association between BP and overall cancer was found for any of the study designs. Although a single cohort study reported an association with lymphoid leukemia and kidney and larynx cancer, a pooled analysis of case-control studies did not. A pooled analysis of cross-sectional studies found a significant association between BP and hematologic malignancies. CONCLUSIONS The paucity of well-designed studies hindered the possibility of proving or disproving the BP-cancer association. CONCLUSIONS We did not find an association of BP with overall malignancy, but a possible association with hematologic malignancy was observed.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010391 Pemphigoid, Bullous A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis. Pemphigoid,Bullous Pemphigoid,Pemphigoids
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D019337 Hematologic Neoplasms Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES. Blood Cancer,Hematologic Malignancies,Hematopoietic Neoplasms,Hematologic Malignancy,Hematological Malignancies,Hematological Neoplasms,Hematopoietic Malignancies,Malignancies, Hematologic,Malignancy, Hematologic,Neoplasms, Hematologic,Neoplasms, Hematopoietic,Blood Cancers,Cancer, Blood,Hematologic Neoplasm,Hematological Malignancy,Hematological Neoplasm,Hematopoietic Malignancy,Hematopoietic Neoplasm,Malignancy, Hematological,Malignancy, Hematopoietic,Neoplasm, Hematologic,Neoplasm, Hematological,Neoplasm, Hematopoietic

Related Publications

Lihi Atzmony, and Ilit Mimouni, and Ofer Reiter, and Yael Anne Leshem, and Omar Taha, and Michael Gdalevich, and Emmilia Hodak, and Daniel Mimouni
December 2021, Journal of the American Academy of Dermatology,
Lihi Atzmony, and Ilit Mimouni, and Ofer Reiter, and Yael Anne Leshem, and Omar Taha, and Michael Gdalevich, and Emmilia Hodak, and Daniel Mimouni
November 2018, The Australasian journal of dermatology,
Lihi Atzmony, and Ilit Mimouni, and Ofer Reiter, and Yael Anne Leshem, and Omar Taha, and Michael Gdalevich, and Emmilia Hodak, and Daniel Mimouni
December 2016, Journal of the European Academy of Dermatology and Venereology : JEADV,
Lihi Atzmony, and Ilit Mimouni, and Ofer Reiter, and Yael Anne Leshem, and Omar Taha, and Michael Gdalevich, and Emmilia Hodak, and Daniel Mimouni
August 2020, JAMA dermatology,
Lihi Atzmony, and Ilit Mimouni, and Ofer Reiter, and Yael Anne Leshem, and Omar Taha, and Michael Gdalevich, and Emmilia Hodak, and Daniel Mimouni
October 2022, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
Lihi Atzmony, and Ilit Mimouni, and Ofer Reiter, and Yael Anne Leshem, and Omar Taha, and Michael Gdalevich, and Emmilia Hodak, and Daniel Mimouni
September 2020, Journal of the American Academy of Dermatology,
Lihi Atzmony, and Ilit Mimouni, and Ofer Reiter, and Yael Anne Leshem, and Omar Taha, and Michael Gdalevich, and Emmilia Hodak, and Daniel Mimouni
January 2024, International journal of dermatology,
Lihi Atzmony, and Ilit Mimouni, and Ofer Reiter, and Yael Anne Leshem, and Omar Taha, and Michael Gdalevich, and Emmilia Hodak, and Daniel Mimouni
March 2022, The British journal of dermatology,
Lihi Atzmony, and Ilit Mimouni, and Ofer Reiter, and Yael Anne Leshem, and Omar Taha, and Michael Gdalevich, and Emmilia Hodak, and Daniel Mimouni
February 2019, The Australasian journal of dermatology,
Lihi Atzmony, and Ilit Mimouni, and Ofer Reiter, and Yael Anne Leshem, and Omar Taha, and Michael Gdalevich, and Emmilia Hodak, and Daniel Mimouni
October 2022, Journal of cosmetic dermatology,
Copied contents to your clipboard!